Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Allergan Limited
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
An 8-Week, Multicenter, Masked, Randomized Trial (with an 18-Week Masked Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared with Sham DEX PS DDS Applicator System in the Treatment of Non Infectious Ocular Inflammation of the Posterior Segment in Patients with Intermediate or Posterior Uveitis
To evaluate the safety and efficacy of the 700 µg DEX PS DDS Applicator System (700 µg dexamethasone) and 350 µg DEX PS DDS Applicator System (350 µg dexamethasone) compared with Sham DEX PS DDS Appli...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
An Open Label (Stage 1) and Randomized (Stage 2), 24-Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
1. To evaluate the safety of an intracameral implant of Bimatoprost PF IC DDS in patients with open-angle glaucoma (OAG) and ocular hypertension (OHT) (OHT evaluated in Stage 2 patients only). 2. To...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
A Double-Blind, Randomised, Parallel group, Safety and Efficacy Pilot Study Comparing Two Botulinum Toxin Type-A Products in the Treatment of Blepharospasm
To compare the efficacy of BOTOX® versus Xeomin® (≥25U/eye; ≥50U total dose) in the treatment of subjects with blepharospasm
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
To explore the safety and efficacy profile of a range of doses of BOTOX for the treatment of premature ejaculation in male patients
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON Study)
The study objectives are to assess: (1) the safety of the treatment; (2) the effects of treatment on the mean change in atrophic lesion area quantified from fundus autofluorescence images; (3) the eff...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Explore the Dose Dependent Response to Three Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by an Open Label Extension Phase in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity
To explore the dose dependent response to 50 U, 100 U and 200 U BOTOX® when injected into the detrusor for the treatment of urinary incontinence caused by neurogenic detrusor overactivity in patients ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
Study of the efficacy and safety of BOTOX® in the treatment of facial wrinkles (crow's feet lines)
To evaluate the safety and efficacy of BOTOX compared to placebo in subjects with lateral canthal rhytides in the periorbital region (Crow's Feet Lines).
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
A Six-Month, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Macular Oedema following Central Retinal Vein Occlusion or Branch Retinal Vein Occlusion
To evaluate the safety and efficacy of the 700 µg DEX PS DDS Applicator System (700 µg dexamethasone) and 350 µg DEX PS DDS Applicator System (350 µg dexamethasone) compared with a Sham DEX PS DDS App...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
A study to evaluate the long-term safety and efficacy of BOTOX® for the treatment of urinary incontinence in patients 8 to 17 years of age
To evaluate the long-term safety and efficacy of BOTOX for the treatment of urinary incontinence due to Neurogenic Detrusor Overactivity (NDO) in patients 8 to 17 years of age who have not been adequa...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Allergan Limited
MAJ Il y a 4 ans
A study to compare a slow release formulation of bimatoprost with selective laser trabeculoplasty in patients with open-angle glaucoma or high pressure in the eye
To evaluate the intraocular pressure (IOP)-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty (SLT) in patients with open-angle glaucoma (OAG) or ocular hyperte...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Précédent
1
2
3
4
Suivant